利弊-话题@MedSci

#利弊#

39篇内容 | 968人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1744809, encodeId=aa771e44809f6, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=JCO：西妥昔单抗联合放化疗治疗HIV相关肛管癌利弊皆有！, objectType=article, longId=99749, objectId=79f199e49ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79f199e49ce, replyNumber=0, likeNumber=25, createdTime=2018-03-15, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79f199e49ce, moduleTitle=JCO：西妥昔单抗联合放化疗治疗HIV相关肛管癌利弊皆有！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79f199e49ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744802, encodeId=f0d51e448020f, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=取消医生编制：利弊难测的双刃剑, objectType=article, longId=74442, objectId=63f3e444232, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63f3e444232, replyNumber=0, likeNumber=30, createdTime=2017-05-31, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63f3e444232, moduleTitle=取消医生编制：利弊难测的双刃剑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63f3e444232)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744804, encodeId=4bb71e4480421, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=【盘点】补充硒对人体健康有啥利弊？, objectType=article, longId=78148, objectId=b32ae81485e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b32ae81485e, replyNumber=0, likeNumber=43, createdTime=2017-05-07, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b32ae81485e, moduleTitle=【盘点】补充硒对人体健康有啥利弊？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b32ae81485e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744803, encodeId=d7e11e4480312, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=JAMA Surg：抗凝治疗小腿孤立性DVT利弊分析, objectType=article, longId=74845, objectId=363be48452b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=363be48452b, replyNumber=0, likeNumber=34, createdTime=2016-09-03, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=363be48452b, moduleTitle=JAMA Surg：抗凝治疗小腿孤立性DVT利弊分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=363be48452b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744801, encodeId=46a71e448017d, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=J Sex Med：性功能辅助药对男性身体利弊的研究, objectType=article, longId=62209, objectId=11656220970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11656220970, replyNumber=0, likeNumber=41, createdTime=2016-10-21, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11656220970, moduleTitle=J Sex Med：性功能辅助药对男性身体利弊的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11656220970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744798, encodeId=6aeb1e447987b, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM：早产儿早期接受全身性糖皮质激素，利弊皆有, objectType=article, longId=57293, objectId=83695e293c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83695e293c9, replyNumber=0, likeNumber=24, createdTime=2016-07-01, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83695e293c9, moduleTitle=NEJM：早产儿早期接受全身性糖皮质激素，利弊皆有, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83695e293c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744799, encodeId=3d8f1e4479900, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM：强化降压，利弊皆有, objectType=article, longId=58599, objectId=ba33585993b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba33585993b, replyNumber=0, likeNumber=33, createdTime=2016-09-19, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba33585993b, moduleTitle=NEJM：强化降压，利弊皆有, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba33585993b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744800, encodeId=46aa1e4480051, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=蜂蜜的利弊——你真的了解吗？, objectType=article, longId=58975, objectId=d658589e556, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d658589e556, replyNumber=0, likeNumber=25, createdTime=2016-03-23, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d658589e556, moduleTitle=蜂蜜的利弊——你真的了解吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d658589e556)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744797, encodeId=56211e447978d, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=妊娠期用药仍需要在权衡利弊，降低出生缺陷, objectType=article, longId=54458, objectId=a6cb544583e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6cb544583e, replyNumber=0, likeNumber=30, createdTime=2016-02-23, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6cb544583e, moduleTitle=妊娠期用药仍需要在权衡利弊，降低出生缺陷, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6cb544583e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744796, encodeId=c38e1e4479606, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=如何权衡不同双联抗血小板疗程的利弊？, objectType=article, longId=51603, objectId=ee055160375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee055160375, replyNumber=0, likeNumber=42, createdTime=2015-12-23, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee055160375, moduleTitle=如何权衡不同双联抗血小板疗程的利弊？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee055160375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744795, encodeId=29531e44795c7, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM：FDA审批Bedaquiline—耐药结核病的利弊权衡, objectType=article, longId=39588, objectId=e35439588ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e35439588ea, replyNumber=0, likeNumber=33, createdTime=2015-01-06, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e35439588ea, moduleTitle=NEJM：FDA审批Bedaquiline—耐药结核病的利弊权衡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e35439588ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744794, encodeId=20481e44794d9, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=Nature：埃博拉试验疗法的利弊, objectType=article, longId=39245, objectId=ccc9392453c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccc9392453c, replyNumber=0, likeNumber=23, createdTime=2015-07-21, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccc9392453c, moduleTitle=Nature：埃博拉试验疗法的利弊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccc9392453c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744793, encodeId=52c71e447932f, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=BMJ：乳腺癌钼靶筛查利弊难评, objectType=article, longId=37280, objectId=5ef53e2801a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ef53e2801a, replyNumber=0, likeNumber=24, createdTime=2014-08-04, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ef53e2801a, moduleTitle=BMJ：乳腺癌钼靶筛查利弊难评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ef53e2801a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744791, encodeId=a49a1e44791ce, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM：围手术期心梗治疗的“阴阳利弊”---POISE-2研究述评, objectType=article, longId=34004, objectId=b9633400470, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9633400470, replyNumber=0, likeNumber=31, createdTime=2014-06-21, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9633400470, moduleTitle=NEJM：围手术期心梗治疗的“阴阳利弊”---POISE-2研究述评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9633400470)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744790, encodeId=6e431e447905d, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=BMJ：应用奥司他韦（达菲）需权衡利弊, objectType=article, longId=33652, objectId=c6123365263, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6123365263, replyNumber=0, likeNumber=32, createdTime=2014-12-15, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6123365263, moduleTitle=BMJ：应用奥司他韦（达菲）需权衡利弊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6123365263)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744792, encodeId=10d21e44792e4, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=Eur Heart J：溶栓治疗对急性肺栓塞患者利弊并存, objectType=article, longId=36403, objectId=5e9136403a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e9136403a7, replyNumber=0, likeNumber=37, createdTime=2015-01-28, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e9136403a7, moduleTitle=Eur Heart J：溶栓治疗对急性肺栓塞患者利弊并存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e9136403a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744789, encodeId=410e1e4478912, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NSCLC:同药维持和换药维持利弊之争, objectType=article, longId=19177, objectId=26df191e781, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26df191e781, replyNumber=0, likeNumber=27, createdTime=2013-06-21, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26df191e781, moduleTitle=NSCLC:同药维持和换药维持利弊之争, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26df191e781)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744788, encodeId=26be1e44788ba, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM:乳房X光筛查的利弊再起争议, objectType=article, longId=11943, objectId=88cd119435d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88cd119435d, replyNumber=0, likeNumber=27, createdTime=2013-07-16, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88cd119435d, moduleTitle=NEJM:乳房X光筛查的利弊再起争议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88cd119435d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744787, encodeId=5cc21e44787cf, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=如何权衡ADT的“利弊”？, objectType=article, longId=2348, objectId=86c02348ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86c02348ce, replyNumber=0, likeNumber=24, createdTime=2011-06-29, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86c02348ce, moduleTitle=如何权衡ADT的“利弊”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86c02348ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

利弊

2020-05-29

lujian (审核中...)

前往app查看评论内容

#利弊#

JCO：西妥昔单抗联合放化疗治疗HIV相关肛管癌利弊皆有！

2018-03-15

lujian (审核中...)

前往app查看评论内容

#利弊#

取消医生编制：利弊难测的双刃剑

2017-05-31

lujian (审核中...)

前往app查看评论内容

#利弊#

【盘点】补充硒对人体健康有啥利弊？

2017-05-07

lujian (审核中...)

前往app查看评论内容

#利弊#

JAMA Surg：抗凝治疗小腿孤立性DVT利弊分析

2016-09-03

lujian (审核中...)

前往app查看评论内容

#利弊#

J Sex Med：性功能辅助药对男性身体利弊的研究

2016-10-21

lujian (审核中...)

前往app查看评论内容

#利弊#

NEJM：早产儿早期接受全身性糖皮质激素，利弊皆有

2016-07-01

lujian (审核中...)

前往app查看评论内容

#利弊#

NEJM：强化降压，利弊皆有

2016-09-19

lujian (审核中...)

前往app查看评论内容

#利弊#

蜂蜜的利弊——你真的了解吗？

2016-03-23

lujian (审核中...)

前往app查看评论内容

#利弊#

妊娠期用药仍需要在权衡利弊，降低出生缺陷

2016-02-23

lujian (审核中...)

前往app查看评论内容

#利弊#

如何权衡不同双联抗血小板疗程的利弊？

2015-12-23

lujian (审核中...)

前往app查看评论内容

#利弊#

NEJM：FDA审批Bedaquiline—耐药结核病的利弊权衡

2015-01-06

lujian (审核中...)

前往app查看评论内容

#利弊#

Nature：埃博拉试验疗法的利弊

2015-07-21

lujian (审核中...)

前往app查看评论内容

#利弊#

BMJ：乳腺癌钼靶筛查利弊难评

2014-08-04

lujian (审核中...)

前往app查看评论内容

#利弊#

NEJM：围手术期心梗治疗的“阴阳利弊”---POISE-2研究述评

2014-06-21

lujian (审核中...)

前往app查看评论内容

#利弊#

BMJ：应用奥司他韦（达菲）需权衡利弊

2014-12-15

lujian (审核中...)

前往app查看评论内容

#利弊#

Eur Heart J：溶栓治疗对急性肺栓塞患者利弊并存

2015-01-28

lujian (审核中...)

前往app查看评论内容

#利弊#

NSCLC:同药维持和换药维持利弊之争

2013-06-21

lujian (审核中...)

前往app查看评论内容

#利弊#

NEJM:乳房X光筛查的利弊再起争议

2013-07-16

lujian (审核中...)

前往app查看评论内容

#利弊#

如何权衡ADT的“利弊”？

2011-06-29

科室
- - 订阅+
  - 更多科室
工具
服务